Navigation Links
Senior Obama Strategist David Axelrod and Wife Susan to be Honored for Their Decade-Long Commitment to Epilepsy Research at NYC Benefit
Date:3/19/2008

ABC's George Stephanopoulos to be Guest Speaker; PARADE Magazine Publisher

Randy Siegel to Emcee May 13 Event, Sponsored by PARADE

NEW YORK, March 19 /PRNewswire/ -- David Axelrod -- one of America's leading political strategists and senior adviser to Senator Barack Obama -- and his wife, Susan, will be honored for their decade of leadership and commitment to epilepsy research at the First Annual New York City Benefit for CURE (Citizens United for Research in Epilepsy). George Stephanopoulos, Chief Washington Correspondent for ABC News and anchor of "This Week with George Stephanopoulos," will be the guest speaker at the May 13 event. PARADE Publisher Randy Siegel will emcee.

The Axelrod's commitment to curing epilepsy is deeply personal. Their daughter Lauren, now 26, has suffered irreversible brain damage as a result of the disease. She began experiencing life-threatening seizures when she was just seven months old.

In 1998, Susan, unwilling to sit back and accept the devastating effects that continued uncontrollable seizures had on their daughter's life, joined forces with two other mothers of children with epilepsy. Together they formed Citizens United for Research in Epilepsy and spearheaded the search for a cure. Since then, CURE has raised $9 million, funded 70 cutting-edge research grants, sponsored scientific conferences and helped change the national dialogue on the disease.

David Axelrod has played an integral role in furthering CURE's mission, spreading the word to his colleagues in Washington and enlisting high-profile help in providing a national voice for those with epilepsy, like his daughter.

"David and Susan have done outstanding work in bringing awareness to this devastating disease," says Siegel, whose own daughter, Rebecca, suffers from epilepsy. "We celebrate their efforts and hope for a cure. That can only happen through continued fundraising and research."

CURE fundraisers and speakers have included Meet the Press host Tim Russert, U.S. Representative Rahm Emanuel, Senator Barack Obama, Senator John Edwards, Senator Hillary Rodham Clinton, and former President Bill Clinton.

About Epilepsy

Epilepsy affects more than 3 million Americans of all ages-more than Multiple Sclerosis, Cerebral Palsy, Muscular Dystrophy, and Parkinson's disease combined-and affects more than 50 million people worldwide. In the U.S., nearly 500 new cases of epilepsy are diagnosed each day. Epilepsy can develop at any age and can be a result of genetics, stroke, head injury, and many other factors. In more than 30 percent of patients, seizures cannot be controlled with treatment. And in two-thirds of patients diagnosed with epilepsy, the cause is unknown. Tens of thousands Americans die annually of this disease.

Visit CURE's Web site at http://www.CUREepilepsy.org for facts about epilepsy, personal stories, research funding, grants and special events.


'/>"/>
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Oral Health a Matter of Life and Death for Seniors
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
4. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
5. Seniors Need a Safety Plan in Face of Disasters
6. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
7. High Co-Pays Cause Seniors to Go Without Meds
8. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
9. Poor Senior Vision Often a Window on Disease
10. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
11. Pharmacopeia Announces Senior Additions to Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... PA (PRWEB) , ... May 05, 2016 , ... ... on long-acting injectables (LAIs), today announced a development collaboration with the ... to treat serious mental disorders such as schizophrenia. , LAI medicines can offer ...
(Date:5/5/2016)... Palm Beach, Fla. (PRWEB) , ... May 05, 2016 , ... ... Vision Institute in San Diego, California. The laser eye center will now be called ... recognized surgeons and attentive staff will remain at the full-service facility to ensure that ...
(Date:5/5/2016)... ... May 05, 2016 , ... LELO has discovered many people ... fans reach out via email, social media and on the Volonté blog seeking advice ... way I masturbate ‘normal’ or ‘correct’?” , While some methods are more common than ...
(Date:5/5/2016)... Fort Collins, CO (PRWEB) , ... May 05, ... ... has announced the commencement of a master charity program created to assist the ... every 60 days, working closely with nonprofit organizations and community leaders. Their hope ...
(Date:5/5/2016)... TX (PRWEB) , ... May 05, 2016 , ... Vitenas ... AIA/AAH Healthcare Design Awards, presented by the American Institute of Architects and the Academy ... designed by the renowned Perkins+Will and Harrell Architects, opened to patients in October of ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Keratosis Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Actinic ... Keratosis market valuations and forecast, Actinic Keratosis ...
(Date:5/3/2016)... 4, 2016 Research and Markets ... Stem Cell Therapy Market Outlook 2020" report to ... ) , ,Recombinant technology has improved significantly in past ... be developed in coming years. Many cancer drugs have ... cell therapies are also expected to be developed with ...
(Date:5/3/2016)... 3, 2016   BIOTRONIK , a leader ... Food and Drug Administration (FDA) approval of Iperia ... heart failure patients with access to diagnostic magnetic ... remote monitoring with daily automatic transmission and closed ... in response to physiological demands. ...
Breaking Medicine Technology: